Tilray Brands, Inc.
NASDAQ:TLRYDrug Manufacturers - Specialty & Generic
-$0.04 today
- Market cap
- $251.62M
- Beta
- 1.88
- P/E (TTM)
- -0.3
- EPS (TTM)
- -$16.38
Volume 5.03M
Average 4.73M
TLRY Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Tilray Brands, Inc.NASDAQ: TLRY
Research & Development · Q3 FY2026 · quarter ended Feb 2026
Research & development declines year over year
Q3 FY2026 research & development of $84.63K fell 31.1% year over year, ahead of the -66.5% change in trailing-twelve-month research & development. Sequentially, it fell 22.3% from the prior quarter. Over 3 fiscal years it compounded at -41.2% a year.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -31.1% holds above the trailing-twelve-month pace of -66.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 389.7K USD
- Year-over-year change
- -55.0%
- 4-year CAGR
- -21.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-05-31 | 389.7K | -55.0% |
| FY2024 | 2024-05-31 | 865.23K | -5.8% |
| FY2023 | 2023-05-31 | 918.64K | -52.0% |
| FY2022 | 2022-05-31 | 1.91M | +90.9% |
| FY2021 | 2021-05-31 | 1M | — |
Research & Development vs competitors
How TLRY compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -66.5% is the lowest of 3, against a peer median of +15.8%.
- Research & development amounts to 0.0% of revenue for TLRY, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$4.98M CAD | +35.4% | +1.4% | 1.6% | |
| LTM Mar 2026 | CA$393K CAD | -3.9% | -41.5% | 0.0% | |
| LTM Feb 2026 | $296.57K USD | -66.5% | -41.2% | 0.0% | |
GLASGlass House Brands Inc | — | — | — | — | — |
| Peer median (excluding TLRY) | — | +15.8% | -20.1% | 0.8% | |
Competitors are the stored peer set for TLRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 May 2021 | FY2022 May 2022 | FY2023 May 2023 | FY2024 May 2024 | FY2025 May 2025 |
|---|---|---|---|---|---|
| Revenue | 619.67M | 792.12M | 844.72M | 1.07B | 1.13B |
| Cost of Revenue | 470.9M | 644.86M | 646.77M | 770.66M | 796.88M |
| Gross Profit | 148.77M | 147.26M | 197.95M | 304.33M | 330.11M |
| Gross Margin | 24.0% | 18.6% | 23.4% | 28.3% | 29.3% |
| Research & Development | 1M | 1.91M | 918.64K | 865.23K | 389.7K |
| Selling, General & Admin | 188.03M | 233.38M | 311.13M | 341.63M | 356.06M |
| Operating Expenses | 308.4M | 916.72M | 2.04B | 542.43M | 3.46B |
| Depreciation & Amortization | 81.92M | 194.88M | 175.31M | 172.93M | 183.17M |
| EBITDA | (297.41M) | (310.61M) | (1.72B) | (99.25M) | (2.92B) |
| EBITDA Margin | -48.0% | -39.2% | -203.1% | -9.2% | -259.0% |
| Operating Income | (159.63M) | (769.46M) | (1.84B) | (238.1M) | (3.13B) |
| Operating Margin | -25.8% | -97.1% | -218.4% | -22.1% | -277.9% |
| Interest Income | 3.53M | 14.79M | 44.48M | 17.48M | 15.61M |
| Interest Expense | 37.32M | 50.02M | 62.79M | 67.13M | 56.71M |
| Other Income / Expenses | (257.02M) | 213.96M | (108.43M) | (101.2M) | (26.99M) |
| Income Before Tax | (416.65M) | (555.51M) | (1.95B) | (339.31M) | (3.16B) |
| Pre-Tax Margin | -67.2% | -70.1% | -231.2% | -31.6% | -280.3% |
| Income Tax Expense | (10.84M) | (8.25M) | (9.67M) | (36.27M) | (166.06M) |
| Net Income | (443.75M) | (601.05M) | (1.96B) | (333.8M) | (3B) |
| Net Margin | -71.6% | -75.9% | -231.6% | -31.1% | -266.3% |
| EPS (Basic) | (13.61) | (9.94) | (31.70) | (4.50) | (33.80) |
| EPS (Diluted) | (13.61) | (9.94) | (31.70) | (4.50) | (33.80) |
| Weighted Avg Shares | 26.95M | 48.12M | 61.8M | 74.26M | 89.03M |
| Weighted Avg Shares (Diluted) | 26.95M | 48.12M | 61.8M | 74.26M | 89.03M |
Tilray Brands, Inc.
NASDAQ:TLRY
Intrinsic Alpha fair value
Locked
Current Price
$2.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.